Qube Research & Technologies (QRT)’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
Qube Research & Technologies (QRT)'s MTRI Position: Q3 2024 in Review
Qube Research & Technologies (QRT) sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2024, closing a stake of 1 share — an estimated $54 sold.
Qube Research & Technologies (QRT) first reported a position in MTRI in Q4 2023 and held it in 3 quarters. The position peaked at $83 in Q4 2023. 9 funds tracked by Wall St. Rank hold MTRI as of Q3 2024.
- Qube Research & Technologies (QRT) reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 1 Mentari Therapeutics, Inc. Common Stock share in Q3 2024, an estimated $54.
- Qube Research & Technologies (QRT) first reported a position in Mentari Therapeutics, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
- Qube Research & Technologies (QRT)'s Mentari Therapeutics, Inc. Common Stock position peaked at $83 in Q4 2023.
- 9 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2024.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.